B takeover of Insmed and its blockbuster lung drug Brinsupri as the French pharma giant braces for Dupixent’s looming patent ...
FDA approval covers AChR-positive generalized myasthenia gravis in adults, introducing a subcutaneous siRNA regimen administered four times annually and expanding complement-directed options beyond ...
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics ...
J&J’s separations of Kenvue and DePuy Synthes test whether Innovative Medicine and MedTech create more value together than ...
Four principles for getting AI agents past the pilot phase in regulated pharma manufacturing. AI agents are the latest technology that organizations are adopting at enterprise scale after finding ...
Moderna used its 2026 Analyst Day to outline an oncology-driven growth strategy anchored by intismeran and other cancer antigen therapies.
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
As specialty drug complexity grows, agentic technology puts the right access, adherence, and affordability resources at the ...
Dr. Joe Geraci of NetraMark explains how AI analysis of clinical trial data can uncover hidden responder subgroups, separate ...
New deals this week span across ophthalmology to Alzheimer’s, with three new acquisitions and one research collaboration.
Parexel’s Stacy Hurt explains why AI can speed up clinical research but can’t replace the lived experience of patients.